Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

678
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
678

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Projection of Interspecific Competition (PIC) Matrices: A Conceptual Framework for Inclusion in Population Risk Assessments.

Environmental toxicology and chemistry·2024
Same author

AOP Report: Adverse Outcome Pathways for Aromatase Inhibition or Androgen Receptor Agonism Leading to Male-Biased Sex Ratio and Population Decline in Fish.

Environmental toxicology and chemistry·2023
Same author

Investigating Vernal Pool Fairy Shrimp Exposure to Organophosphate Pesticides: Implications for Population-Level Risk Assessment.

Ecologies·2022
Same author

A Multidimensional Matrix Model for Predicting the Effects of Male-Biased Sex Ratios on Fish Populations.

Environmental toxicology and chemistry·2022
Same author

A 30-Year Study of Impacts, Recovery, and Development of Critical Effect Sizes for Endocrine Disruption in White Sucker (<i>Catostomus commersonii</i>) Exposed to Bleached-Kraft Pulp Mill Effluent at Jackfish Bay, Ontario, Canada.

Frontiers in endocrinology·2021
Same author

A multidimensional density dependent matrix population model for assessing risk of stressors to fish populations.

Ecotoxicology and environmental safety·2020

Related Experiment Video

Updated: Mar 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K

Diagnosis of multiple sclerosis: progress and challenges.

Wallace J Brownlee1, Todd A Hardy2, Franz Fazekas3

  • 1Queen Square Multiple Sclerosis Centre, University College London (UCL) Institute of Neurology, London, UK.

Lancet (London, England)
|November 28, 2016
PubMed
Summary

Accurate multiple sclerosis diagnosis relies on neurological signs and MRI evidence of central nervous system lesions. Advanced testing improves accuracy, but differentiating it from mimics remains a challenge.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K

Related Experiment Videos

Last Updated: Mar 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.8K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K

Area of Science:

  • Neurology
  • Neuroimaging
  • Immunology

Background:

  • Multiple sclerosis (MS) diagnosis hinges on clinical presentation and evidence of CNS lesions in space and time.
  • Magnetic Resonance Imaging (MRI) is crucial, but cerebrospinal fluid analysis and neurophysiological tests aid in ambiguous cases.
  • Distinguishing MS from other demyelinating and non-demyelinating mimics is critical for appropriate patient management.

Purpose of the Study:

  • To review progress and challenges in diagnosing multiple sclerosis.
  • To discuss diagnostic criteria, differential diagnoses, and uncertainties in MS diagnosis.
  • To explore future prospects in improving the accuracy of multiple sclerosis diagnosis.

Main Methods:

  • Review of diagnostic criteria for multiple sclerosis.
  • Analysis of differential diagnoses mimicking multiple sclerosis.
  • Evaluation of advancements in MRI, serological, and genetic testing for MS diagnosis.

Main Results:

  • MRI and clinical findings are primary diagnostic tools for multiple sclerosis.
  • Cerebrospinal fluid examination and neurophysiological testing provide supportive evidence.
  • Despite advances, misdiagnosis of multiple sclerosis can still occur due to overlapping conditions.

Conclusions:

  • Accurate diagnosis of multiple sclerosis requires integrating clinical, imaging, and laboratory findings.
  • Differentiating multiple sclerosis from mimics like neuromyelitis optica spectrum disorder and chronic small vessel disease is essential.
  • Ongoing advancements in diagnostic technologies promise to enhance the precision of multiple sclerosis diagnosis.